1. Temporary policy regarding non-standard PPE practices for sterile compounding by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Compliance, April 2020 Subject(s): Drug Compounding -- methodsPersonal Protective Equipment -- supply & distributionCOVID-19Sterilization -- methodsUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
